Toll Free: 1-888-928-9744

IgE Allergy Blood Tests - Medical Devices Pipeline Assessment, 2016

Published: Mar 11, 2016 | Pages: 41 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

IgE Allergy Blood Tests - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "IgE Allergy Blood Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of IgE Allergy Blood Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key IgE Allergy Blood Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the IgE Allergy Blood Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of IgE Allergy Blood Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons To Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of IgE Allergy Blood Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents
1 Table of Contents 2 1.1 List of Tables 4 1.2 List of Figures 5 2 Introduction 6 2.1 IgE Allergy Blood Tests Overview 6 3 Products under Development 7 3.1 IgE Allergy Blood Tests - Pipeline Products by Stage of Development 7 3.2 IgE Allergy Blood Tests - Pipeline Products by Territory 8 3.3 IgE Allergy Blood Tests - Pipeline Products by Regulatory Path 9 3.4 IgE Allergy Blood Tests - Pipeline Products by Estimated Approval Date 10 4 IgE Allergy Blood Tests - Pipeline Products under Development by Companies 11 4.1 IgE Allergy Blood Tests Companies - Pipeline Products by Stage of Development 11 4.2 IgE Allergy Blood Tests - Pipeline Products by Stage of Development 12 5 IgE Allergy Blood Tests Companies and Product Overview 13 5.1 Abionic SA Company Overview 13 5.1.1 Abionic SA Pipeline Products & Ongoing Clinical Trials Overview 13 5.2 Amerimmune Company Overview 15 5.2.1 Amerimmune Pipeline Products & Ongoing Clinical Trials Overview 15 5.3 Atomo Diagnostics Pty Limited Company Overview 17 5.3.1 Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 17 5.4 AXO Science S.A.S. Company Overview 18 5.4.1 AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview 18 5.5 Biovator AB Company Overview 20 5.5.1 Biovator AB Pipeline Products & Ongoing Clinical Trials Overview 20 5.6 Children's Hospital Boston Company Overview 21 5.6.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 21 5.7 China Medical Technologies, Inc. Company Overview 23 5.7.1 China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23 5.8 Cytognos, S.L. Company Overview 25 5.8.1 Cytognos, S.L. Pipeline Products & Ongoing Clinical Trials Overview 25 5.9 HOB Biotech Group Co., Ltd. Company Overview 26 5.9.1 HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 26 5.10 Hycor Biomedical Inc. Company Overview 27 5.10.1 Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 27 5.11 Institut fur Produktqualitat GmbH Company Overview 30 5.11.1 Institut fur Produktqualitat GmbH Pipeline Products & Ongoing Clinical Trials Overview 30 5.12 The Binding Site Group Ltd. Company Overview 31 5.12.1 The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31 5.13 The University of Queensland Company Overview 32 5.13.1 The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 32 5.14 University of Connecticut Health Center Company Overview 33 5.14.1 University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview 33 5.15 University of Nottingham Company Overview 34 5.15.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 34 5.16 VEGA Ltd Company Overview 36 5.16.1 VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview 36 6 IgE Allergy Blood Tests- Recent Developments 37 7 Appendix 38 7.1 Methodology 38 7.2 About GlobalData 40 7.3 Contact Us 41 7.4 Disclaimer 41
List of Tables
Table 1: IgE Allergy Blood Tests - Pipeline Products by Stage of Development 7 Table 2: IgE Allergy Blood Tests - Pipeline Products by Territory 8 Table 3: IgE Allergy Blood Tests - Pipeline Products by Regulatory Path 9 Table 4: IgE Allergy Blood Tests - Pipeline Products by Estimated Approval Date 10 Table 5: IgE Allergy Blood Tests Companies - Pipeline Products by Stage of Development 11 Table 6: IgE Allergy Blood Tests - Pipeline Products by Stage of Development 12 Table 7: Abionic SA Pipeline Products & Ongoing Clinical Trials Overview 13 Table 8: abioKIT - Product Status 14 Table 9: abioKIT - Product Description 14 Table 10: Amerimmune Pipeline Products & Ongoing Clinical Trials Overview 15 Table 11: Basophile Panel - Product Status 15 Table 12: Basophile Panel - Product Description 15 Table 13: CD69 and IgE Receptor Expression Assay - Product Status 16 Table 14: CD69 and IgE Receptor Expression Assay - Product Description 16 Table 15: Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 17 Table 16: AtomoRapid - Allergy - Product Status 17 Table 17: AtomoRapid - Allergy - Product Description 17 Table 18: AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview 18 Table 19: Companion Diagnostic Test - Allergy - Product Status 18 Table 20: Companion Diagnostic Test - Allergy - Product Description 18 Table 21: Diagnostic Test - Allergy - Product Status 19 Table 22: Diagnostic Test - Allergy - Product Description 19 Table 23: Biovator AB Pipeline Products & Ongoing Clinical Trials Overview 20 Table 24: Cytokine Profile Assay - Product Status 20 Table 25: Cytokine Profile Assay - Product Description 20 Table 26: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 21 Table 27: Biomarker Assay - Allergy - Product Status 22 Table 28: Biomarker Assay - Allergy - Product Description 22 Table 29: China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23 Table 30: Diagnostic Assay - Total IgE - Product Status 24 Table 31: Diagnostic Assay - Total IgE - Product Description 24 Table 32: Cytognos, S.L. Pipeline Products & Ongoing Clinical Trials Overview 25 Table 33: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Status 25 Table 34: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Description 25 Table 35: HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 26 Table 36: HOB Biotech Diagnostic Assay - Allergy - Product Status 26 Table 37: HOB Biotech Diagnostic Assay - Allergy - Product Description 26 Table 38: Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 27 Table 39: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Status 28 Table 40: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Description 28 Table 41: HYTEC 288 PLUS - Tryptase Test - Product Status 29 Table 42: HYTEC 288 PLUS - Tryptase Test - Product Description 29 Table 43: Institut fur Produktqualitat GmbH Pipeline Products & Ongoing Clinical Trials Overview 30 Table 44: Diagnostic Test - Allergy - Product Status 30 Table 45: Diagnostic Test - Allergy - Product Description 30 Table 46: The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31 Table 47: SPAplus - Immunoglobulin E Assay - Product Status 31 Table 48: SPAplus - Immunoglobulin E Assay - Product Description 31 Table 49: The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 32 Table 50: Diagnostic Assay - Allergy - Product Status 32 Table 51: Diagnostic Assay - Allergy - Product Description 32 Table 52: University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview 33 Table 53: Ultrasensitive Peanut Allergy Test - Product Status 33 Table 54: Ultrasensitive Peanut Allergy Test - Product Description 33 Table 55: University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 34 Table 56: Allergy Test - Product Status 35 Table 57: Allergy Test - Product Description 35 Table 58: VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview 36 Table 59: Microarray Based Allergen Diagnostic Kit - Product Status 36 Table 60: Microarray Based Allergen Diagnostic Kit - Product Description 36 Table 61: Glossary 39


List of Figures
Figure 1: IgE Allergy Blood Tests - Pipeline Products by Stage of Development 7 Figure 2: IgE Allergy Blood Tests - Pipeline Products by Territory 8 Figure 3: IgE Allergy Blood Tests - Pipeline Products by Regulatory Path 9 Figure 4: IgE Allergy Blood Tests - Pipeline Products by Estimated Approval Date 10

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global non halogenated flame retardants market size is anticipated to be valued at USD 2.54 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing safety materials demand owing to low heat & smoke emission properties in c

Read More...

Global intelligent transportation system (ITS) market is estimated to attain USD 38.68 billion by 2020, as per a new research report by Radiant Insights, Inc. Cost effectiveness along with escalating need for road safety is likely to boost global dem

Read More...

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...

Global activated carbon market size is likely to be valued at USD 5.3 billion by 2020; as per a new research report by Radiant Insights, Inc. Increase in commercial & residential waste water treatment demand owing to escalation in water prices is ant

Read More...

Global Bio polyethylene terephthalate (PET) market size is likely to be valued at USD 12.6 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing preference of biopolymers in numerous applications coupled with favorable gover

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify